NCT00762502 arm group f5eed7a084e65580d93ffb223ced9e4e [clinicaltrials_resource:NCT00762502/arm-group/f5eed7a084e65580d93ffb223ced9e4e]
NCT00762502 arm group f5eed7a084e65580d93ffb223ced9e4e [clinicaltrials_resource:NCT00762502/arm-group/f5eed7a084e65580d93ffb223ced9e4e]
Bio2RDF identifier
NCT00762502/arm-group/f5eed7a084e65580d93ffb223ced9e4e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... eed7a084e65580d93ffb223ced9e4e
description [clinicaltrials_vocabulary:description]
senofilcon A lenses worn daily bilaterally (in both eyes) for 3 months, replaced weekly.
identifier
clinicaltrials_resource:NCT00762502/arm-group/f5eed7a084e65580d93ffb223ced9e4e
title
NCT00762502 arm group f5eed7a084e65580d93ffb223ced9e4e
@en
type
label
NCT00762502 arm group f5eed7a0 ...... ed7a084e65580d93ffb223ced9e4e]
@en